405 related articles for article (PubMed ID: 27041824)
1. The Role of Protein Arginine Methyltransferases in Inflammatory Responses.
Kim JH; Yoo BC; Yang WS; Kim E; Hong S; Cho JY
Mediators Inflamm; 2016; 2016():4028353. PubMed ID: 27041824
[TBL] [Abstract][Full Text] [Related]
2. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
Elife; 2022 Jan; 11():. PubMed ID: 34984976
[TBL] [Abstract][Full Text] [Related]
3. Functional Study of
Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
[TBL] [Abstract][Full Text] [Related]
4. Genome wide comparative analysis of the effects of PRMT5 and PRMT4/CARM1 arginine methyltransferases on the Arabidopsis thaliana transcriptome.
Hernando CE; Sanchez SE; Mancini E; Yanovsky MJ
BMC Genomics; 2015 Mar; 16(1):192. PubMed ID: 25880665
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferases (PRMTs) as therapeutic targets.
Cha B; Jho EH
Expert Opin Ther Targets; 2012 Jul; 16(7):651-64. PubMed ID: 22621686
[TBL] [Abstract][Full Text] [Related]
6. Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases.
Bao J; Di Lorenzo A; Lin K; Lu Y; Zhong Y; Sebastian MM; Muller WJ; Yang Y; Bedford MT
Cancer Res; 2019 Jan; 79(1):21-32. PubMed ID: 30352814
[TBL] [Abstract][Full Text] [Related]
7. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
Yoshimatsu M; Toyokawa G; Hayami S; Unoki M; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):562-73. PubMed ID: 20473859
[TBL] [Abstract][Full Text] [Related]
9. Protein arginine methyltransferases (PRMTs): role in chromatin organization.
Jahan S; Davie JR
Adv Biol Regul; 2015 Jan; 57():173-84. PubMed ID: 25263650
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Drosophila protein arginine methyltransferases DART1 and DART4.
Boulanger MC; Miranda TB; Clarke S; Di Fruscio M; Suter B; Lasko P; Richard S
Biochem J; 2004 Apr; 379(Pt 2):283-9. PubMed ID: 14705965
[TBL] [Abstract][Full Text] [Related]
11. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
[TBL] [Abstract][Full Text] [Related]
12. Human protein arginine methyltransferases in vivo--distinct properties of eight canonical members of the PRMT family.
Herrmann F; Pably P; Eckerich C; Bedford MT; Fackelmayer FO
J Cell Sci; 2009 Mar; 122(Pt 5):667-77. PubMed ID: 19208762
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of protein methylation in melanoma.
Limm K; Ott C; Wallner S; Mueller DW; Oefner P; Hellerbrand C; Bosserhoff AK
Eur J Cancer; 2013 Apr; 49(6):1305-13. PubMed ID: 23265702
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine methylation of non-histone proteins and its role in diseases.
Wei H; Mundade R; Lange KC; Lu T
Cell Cycle; 2014; 13(1):32-41. PubMed ID: 24296620
[TBL] [Abstract][Full Text] [Related]
15. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
16. Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems.
Wang YC; Li C
FEBS J; 2012 Mar; 279(6):932-45. PubMed ID: 22251447
[TBL] [Abstract][Full Text] [Related]
17. Human protein arginine methyltransferases (PRMTs) can be optimally active under nonphysiological conditions.
Lowe TL; Clarke SG
J Biol Chem; 2022 Sep; 298(9):102290. PubMed ID: 35868559
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
Gao Y; Feng C; Ma J; Yan Q
Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
[TBL] [Abstract][Full Text] [Related]
19. Peptidic transition state analogues as PRMT inhibitors.
Zhang Y; van Haren MJ; Martin NI
Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
[TBL] [Abstract][Full Text] [Related]
20. Plant PRMTs broaden the scope of arginine methylation.
Ahmad A; Cao X
J Genet Genomics; 2012 May; 39(5):195-208. PubMed ID: 22624881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
